S. 569 would accelerate efforts to develop vaccines for diseases primarily affecting developing countries.
Detailed Summary
Vaccines for the Future Act of 2007 - Directs the President to establish a comprehensive strategy to accelerate efforts to develop vaccines and microbicides for neglected diseases such as HIV/AIDS, malaria, and tuberculosis.
States that such strategy shall: (1) expand public-private partnerships and seek to leverage foreign country and private sector resources; (2) include the negotiation of advance market commitments and other economic incentives for the research, development, and manufacturing of vaccines and microbicides for HIV/AIDS, tuberculosis, malaria, and other neglected diseases; (3) address related intellectual property and regulatory issues; (4) maximize U.S. capabilities to support clinical trials of vaccines and microbicides in developing countries; and (5) expand the purchase and delivery of existing vaccines.
Directs the Secretary of the Treasury to enter into negotiations with the World Bank, the International Development Association, the GAVI Alliance, such entities' member nations, and other interested parties to establish advance market commitments to purchase vaccines and microbicides to combat neglected diseases. (Defines "GAVI Alliance" as the public-private partnership launched in 2000 for the purpose of saving children and protecting all people through the widespread use of vaccines.)
Status of the Legislation
Latest Major Action: 2/13/2007: Referred to Senate committee. Status: Read twice and referred to the Committee on Foreign Relations.
Points in Favor
(Log in to edit the wiki and be the first to show why the bill should pass!)
Points Against
(Log in to edit the wiki and be the first to show why the bill should not pass!)
Visitor Comments
There are currently no comments for this bill.